Ambey Laboratories Ltd

Ambey Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Ambey Laboratories Ltd

₹ 40.0 2.44%
01 Jul - close price
Company website NSE - SME: AMBEY
About

Incorporated in 1985, Ambey Laboratories manufactures agrochemical products for crop protection.[1]

Key Points

Agro Chemical Products[1]
2,4-D Amine Salt (480 gm. Liter SL)
2,4-D Amine Salt (625 gm. Liter SL)
2,4-D Amine Salt (720 gm. Liter SL)
2,4-D Amine Salt (806 gm. Liter SL)
2,4-D Amine Salt (840 gm. Liter SL)
2,4-D Amine Salt (866 gm. Liter SL)
2,4-D Acid Tech (98% min)
2,4-D Ethyl Ester Tech (95% min)
2,4-D 2-Ethylhexyl Ester Tech (96% min)
2,4-D Sodium Salt (95% min)
Hexaconazole (5% min)

Website NSE - SM
  • Market Cap ₹ 99.7 Cr.
  • Current Price ₹ 40.0
  • High / Low ₹ 97.2 / 31.8
  • Stock P/E 20.8
  • Book Value ₹ 30.6
  • Dividend Yield 0.00 %
  • ROCE 9.62 %
  • ROE 8.86 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company might be capitalizing the interest cost
  • Debtor days have increased from 60.5 to 112 days.
  • Working capital days have increased from 107 days to 209 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Mar 2024 Sep 2024 Mar 2025
60 68 64
56 62 60
Operating Profit 4 6 4
OPM % 7% 9% 6%
1 1 1
Interest 1 2 1
Depreciation 1 1 2
Profit before tax 3 4 2
Tax % 33% 18% 25%
2 3 2
EPS in Rs 0.94 1.19 0.73
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
82 85 105 120 131
72 74 97 111 122
Operating Profit 10 10 8 9 10
OPM % 12% 12% 7% 8% 7%
1 1 3 1 2
Interest 4 3 2 2 3
Depreciation 3 3 3 3 3
Profit before tax 3 5 6 5 6
Tax % -235% 26% 5% -42% 21%
10 4 5 8 5
EPS in Rs 211.28 20.11 29.52 4.13 1.92
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 16%
TTM: 9%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 10%
TTM: -40%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 18%
Last Year: 9%

Balance Sheet

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 5 18 18 19 25
Reserves -13 1 1 13 51
33 18 14 30 41
20 19 21 18 10
Total Liabilities 45 56 54 79 127
16 25 25 24 23
CWIP 1 0 0 4 16
Investments 0 0 1 1 0
28 31 28 51 88
Total Assets 45 56 54 79 127

Cash Flows

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
3 6 10 -13 -34
-1 -1 -4 -5 -14
-1 -5 -6 14 48
Net Cash Flow 0 -0 0 -4 0

Ratios

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 31 37 12 57 112
Inventory Days 78 75 93
Days Payable 74 54 21
Cash Conversion Cycle 31 37 17 78 185
Working Capital Days 5 27 22 90 209
ROCE % 25% 22% 17% 10%

Shareholding Pattern

Numbers in percentages

Sep 2024Mar 2025
69.90% 70.11%
1.46% 0.01%
4.11% 2.34%
24.53% 27.54%
No. of Shareholders 1,5201,327

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings